This patent describes peptides derived from hemoglobin that inhibit stem cell proliferation. These peptides are useful for protecting stem cells from killing by chemotherapy or radiation therapy.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.